The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

GMED FINANCIAL STATEMENTS

Globus Medical — balance sheet, income statement and cash flow trends

GMEDGlobus Medical

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
01 B2 B3 B202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue3.1 B $Gross Profit2.2 B $ · 69%Operating Income652.7 M $ · 21%Pre-tax Income665 M $ · 21%Net Income to Owners535.5 M $ · 17%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue3.1 B $+19.7%
Gross Profit2.2 B $+30.8%
Operating Income652.7 M $+131.9%
EBITDA876.3 M $+41.6%
Net Income to Owners535.5 M $+50.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
02 B4 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets5.5 B
  • Equity4.8 B $87%
  • Current Liabilities479.3 M $9%
  • Long-term Liabilities240.3 M $4%

Key Figures

YoY change
Total Assets5.5 B $+10.6%
Total Liabilities719.7 M $+8.2%
Total Equity4.8 B $+11.0%
Cash & ST Investments595.1 M $+159.4%
Total Debt111.2 M $-8.2%
Net Debt-396.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0500 M1 B202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
0500 M1 B1.1 B $Operating-681.7 M $Investing-116.9 M $Financing314.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow1.1 B $+66.3%
Capital Expenditures199.4 M $+31.4%
Free Cash Flow913.3 M $+76.5%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on GMED

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.